Haloperidol: Indications, Contraindications, Onset, and Duration
Haloperidol is indicated for psychotic disorders, Tourette's disorder, and severe behavioral problems in children; it is contraindicated in severe CNS depression, coma, hypersensitivity, and Parkinson's disease, with onset of action within 2 hours and duration of 4-6 hours for intramuscular administration. 1
Indications
Haloperidol tablets are FDA-approved for 1:
- Psychotic disorders (management of manifestations)
- Tourette's disorder (control of tics and vocal utterances in children and adults)
- Severe behavior problems in children with combative, explosive hyperexcitability
- Hyperactive children with conduct disorders (impulsivity, difficulty sustaining attention, aggressivity, mood lability, poor frustration tolerance) - reserved only after failure of psychotherapy or other non-antipsychotic medications
Off-label emergency use: Haloperidol is widely used for acute agitation in emergency settings. Guidelines support its use as effective monotherapy for acutely agitated undifferentiated patients 2. However, in geriatric patients, quetiapine shows lower adverse event rates compared to haloperidol, while midazolam poses excessive risk 3.
Contraindications
Haloperidol is absolutely contraindicated in 1:
- Severe toxic CNS depression or comatose states from any cause
- Hypersensitivity to haloperidol
- Parkinson's disease
Clinical caveat: The FDA black box warning on droperidol (a related butyrophenone) raised concerns about QT prolongation, though large series suggest this risk may be overstated 2. Haloperidol can also prolong QT interval, so avoid in patients with significant cardiac conduction abnormalities.
Onset of Action
Intramuscular haloperidol begins working within 2 hours, with evidence of antipsychotic effects on core psychosis (not just sedation) detectable within the first 24 hours 4. Specifically:
- IM administration: Mean time to sedation approximately 28 minutes in comparative studies 2
- Psychotic symptom improvement: Measurable within 2-24 hours 4
- The antipsychotic action is more proximally related to dopamine blockade than previously thought, explaining this rapid onset 4
This contradicts older beliefs about delayed antipsychotic action - the therapeutic effect on psychosis itself (conceptual disorganization, hallucinations, unusual thought content) begins early and grows with time 4.
Duration of Action
Intramuscular haloperidol requires dosing every 4-6 hours 2:
- Standard IM dosing: 2.5-10 mg every 4-6 hours as needed
- Mean time to arousal after initial IM dose: approximately 126 minutes (just over 2 hours) 2
Haloperidol decanoate (long-acting depot formulation):
- Half-life: 21 days 5
- Justifies monthly administration 5
- Conversion factor: approximately 15-20 times the oral daily dose 5
Practical Dosing Considerations
For older adults (≥65 years): Low-dose injectable haloperidol (≤0.5 mg) demonstrates similar efficacy to higher doses with better outcomes including shorter length of stay and less restraint use 6. Start with 0.5-1 mg IM/IV in older patients rather than standard 5-10 mg doses.
For acute agitation: Guidelines recommend haloperidol 5-10 mg IM as effective monotherapy, with combination therapy (haloperidol plus lorazepam) potentially producing more rapid sedation than monotherapy 2. However, if rapid sedation is specifically required, consider droperidol instead of haloperidol 2.
Drug interactions: Avoid strong CYP inducers (carbamazepine, phenobarbital, phenytoin, rifampin) which require dose increases of 2-5 fold. Avoid fluvoxamine and combinations of CYP3A4/CYP2D6 inhibitors 7.